Brief: ObsEva Announces Dismissal Of Moratorium Proceedings
19/12/2022 12:24
Dec 19 (Reuters) - ObsEva SA OBSN.S :
* OBSEVA ANNOUNCES DISMISSAL OF MORATORIUM PROCEEDINGS
* OBSEVA SA - RESOLVED OVER-INDEBTEDNESS DUE TO SALE OF ALL
ITS
RIGHTS TO EBOPIPRANT TO XOMA CORPORATION (XOMA) FOR AN UPFRONT
PAYMENT OF $15 MILLION
* OBSEVA SA - OBSEVA RETAINS WORLDWIDE, EXCLUSIVE,
COMMERCIAL
RIGHTS FOR NOLASIBAN, EXCEPT FOR PEOPLE'S REPUBLIC OF CHINA
Source text for Eikon: ID:nGNX4lcFVJ
Further company coverage: OBSN.S
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Obseva SA
See all newsBrief: Obseva Announces Wind-Down Of Operations And Likely Not Going To Be Able To Satisfy Requirements For Maintaining Its Listing
Brief: Obseva Applies For Moratorium To Facilitate Pivotal Deals
Brief: Obseva SA Says Xoma Will Receive Full Worldwide Rights On Ebopiprant Following Termination Of License Agreement With Organon
Brief: Obseva Appoints Fabien De Ladonchamps As Chief Executive Officer Effective May 1, 2023
Brief: Obseva Announces Change Of Central Securities Depositary